Crunching the data: New liver cancer subtypes revealed immunologically

February 01, 2019

A research team based at Tokyo Medical and Dental University (TMDU) has used an integrated data analysis to classify hepatocellular carcinoma, the most common type of liver cancer, into three distinct subgroups, which should aid targeted treatment

Tokyo, Japan - Liver cancer remains a major problem in healthcare globally, being the second most common cause of cancer-related death globally. Previous studies showed that this disease, especially its predominant form hepatocellular carcinoma (HCC), exhibits substantial heterogeneity. However, efforts to categorize HCC more precisely have been limited by an inability to integrate data from various sources into a single classification system.

A Tokyo Medical and Dental University (TMDU)-centered research group has made a major advance in this field by combining data on mutations, gene expression patterns, and immunological status to shed light on the variation among cases of HCC. The study, recently reported in the journal EBioMedicine, reveals that there are actually three distinct types of this disease, which should help in predicting the prognosis of individual patients and treating them more effectively (Fig 1).

The team first extracted a range of data on 183 removed HCC tumor specimens and then used statistical analysis to see if they clustered together into specific groups with distinct features. They then tested whether their findings were supported by an additional analysis of data from 373 HCC patients, and also incorporated data on each patient's characteristics such as their clinical course and overall outcome.

"We knew that we'd have to take a large number of different variables into account in order to establish clinically useful stratification of HCC," corresponding author Shinji Tanaka says. He adds, "our combination of genomic, epigenomic, and transcriptomic data and immune system characterization provided new insights into this disease."

Among the three types of HCC revealed by the observations, one included tumors with mutation in the CTNNB1 gene along with a suppressed immune system (Fig 2). Another featured tumors in those with metabolic disease, associated with conditions such as obesity, diabetes, and dyslipidemia, rather than having an association with hepatitis virus infection as typically found in other cases. Finally, in the third group, the tumors showed mitogenic features and chromosomal instability, and a worse patient prognosis (Fig 3).

"If we can use this new classification to group HCC patients according to their subtype, it should help us provide the specific treatment that's best for them," lead author Shu Shimada of TMDU says. "Our finding of a metabolic disease-related subtype is also particularly important given the rate at which diseases such as obesity and diabetes are becoming more and more prevalent."

The article "Comprehensive molecular and immunological characterization of hepatocellular carcinoma" is published in EBioMedicine at doi: 10.1016/j.ebiom.2018.12.058.
-end-


Tokyo Medical and Dental University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.